Please enable Javascript to use all features and improve your user experience.
DPC 2024
Programme
Search
EN
All people
Mr. Philipp Hafner
Freiburg im Breisgau / DE
Universitätsklinikum Freiburg
Sort by Type
Date
Speaker
Sa, 17/02
10:50
–
10:55
3 Min.
2 Min.
ePoster presentation
P54
Impact of targeted SHP2-inhibition +/- MAPK-Inhibition on metabolic rewiring in pancreatic cancer
Pancreatic cancer
Further involvements
Th, 15/02
16:40
–
16:45
3 Min.
2 Min.
ePoster presentation
P20
Mechanisms of resistance to targeted SHP2-inhibition +/- MAPK- or KRAS
G12D
-inhibition in pancreatic cancer
Pancreatic cancer
Th, 15/02
18:10
–
18:20
8 Min.
2 Min.
Oral presentation
O17
Tumor-immune-microenvironmental implications of targeted SHP2-inhibition +/- MAPK-inhibition in pancreatic cancer
Pancreatic cancer
Sa, 17/02
10:50
–
10:55
3 Min.
2 Min.
ePoster presentation
P54
Impact of targeted SHP2-inhibition +/- MAPK-Inhibition on metabolic rewiring in pancreatic cancer
Pancreatic cancer
Sa, 17/02
11:50
–
11:55
3 Min.
2 Min.
ePoster presentation
P75
Implications of targeted SHP2-inhibition +/- MAPK-inhibition on cancer-associated fibroblasts in pancreatic cancer
Tumour microenvironment, epigenetics and stem cells
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy